KURIAKOSE EMIL (Chief Medical Officer) sold 2.2% of their position (1.16K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $44.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/6/2026ACC: 0001892413-26-000002
Officer· Chief Medical Officer
Since Mar 2024
-1.16K
Net shares
Net seller
$44.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−200.00
Price / share
$39.60
Trade value
$7.92K
% of position
0.4%
1/2/2026
51.52K→51.32K
Common Stock
Direct
Shares
−955.00
Price / share
$38.36
Trade value
$36.63K
% of position
1.9%
1/2/2026
51.32K→50.37K
Total
Net shares
−1.16K
Net value
-$44.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −200.00 | $39.60 | $7.92K | 0.4% | 51.52K | 51.32K |
| Common Stock Direct | 1/2/2026 | S · Sale | −955.00 | $38.36 | $36.63K | 1.9% | 51.32K | 50.37K |
| Total | −1.16K | -$44.55K | ||||||
Derivative Transactions0
No derivative transactions reported